Devices › Prosthesis, shoulder, hemi-, humeral, metallic uncemented
Device brand name · Shoulder metaglene
Unknown Shoulder Metaglene: medical device reports filed with FDA
305 reports name it, 2018–2026. Manufacturer given most often on reports: Depuy Orthopaedics US. Product code HSD.
- 305
- device reports naming the brand
- 0% of all MAUDE reports · about 36 a year
- 16
- reports, 12 months to August 2026
- 21 in the 12 months before
- 8.5%
- classified as malfunction
- 15.3% across the product code
- 0.3%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 305 reports that name the brand "Unknown Shoulder Metaglene" (shoulder metaglene), received between January 2018 and March 2026; the manufacturer given most often on reports is Depuy Orthopaedics US. Spellings of one product vary from report to report.
16 reports arrived in the 12 months to August 2026, down 24% from 21 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (91.1%), malfunction (8.5%) and death (0.3%); across all prosthesis, shoulder, hemi-, humeral, metallic uncemented reports (product code HSD) death is recorded in 0.3% and malfunction in 15.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are osseointegration problem (13.8%), device dislodged or dislocated (12.5%) and loss of osseointegration (9.5%). The patient problems coded most often are inadequate osseointegration, pain and not applicable. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 10,267 reports carrying product code HSD. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Osseointegration problem | 42 | 13.8% | 2.6% |
| Device dislodged or dislocated | 38 | 12.5% | 14.8% |
| Loss of osseointegration | 29 | 9.5% | 2.9% |
| Difficult to insertthe device was hard to insert | 19 | 6.2% | 1.8% |
| Insufficient device problem information | 18 | 5.9% | 13.2% |
| Loss of or failure to bond | 5 | 1.6% | 1.6% |
| Failure to osseointegrate | 4 | 1.3% | 0.1% |
| Device-device incompatibility | 3 | 1% | 0.2% |
| Disassembly | 3 | 1% | 1% |
| Disconnection | 3 | 1% | 0% |
| Malposition of device | 3 | 1% | 0.9% |
| Migrationthe device moved from where it was placed | 3 | 1% | 0.7% |
| Detachment of device or device componentpart of the device came off | 2 | 0.7% | 1.1% |
| Difficult to removethe device was hard to remove | 1 | 0.3% | 0.3% |
| Fracturea broken bone | 1 | 0.3% | 5.5% |
| Improper or incorrect procedure or method | 1 | 0.3% | 0.2% |
| Inadequacy of device shape and/or size | 1 | 0.3% | 0.6% |
| Loose or intermittent connection | 1 | 0.3% | 1.7% |
| Noise, audible | 1 | 0.3% | 0.2% |
| Patient-device incompatibilitythe device did not suit the patient | 1 | 0.3% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Inadequate osseointegration | 58 | 19% |
| Painpain, site not specified | 55 | 18% |
| Not applicable | 36 | 11.8% |
| Bone fracture(s) | 25 | 8.2% |
| Hematomaa collection of blood under the skin or in tissue | 22 | 7.2% |
| Joint laxity | 20 | 6.6% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 15 | 4.9% |
| Loss of range of motion | 11 | 3.6% |
| Injurya physical injury | 9 | 3% |
| Nerve damage | 8 | 2.6% |
| Extraskeletal ossification | 6 | 2% |
| Joint dislocationa dislocated joint | 4 | 1.3% |
| Discomfortdiscomfort | 3 | 1% |
| Hypersensitivity/allergic reaction | 3 | 1% |
| Falla fall | 2 | 0.7% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Unknown Shoulder Metaglene | Product code HSD | All MAUDE reports |
|---|---|---|---|
| Reports | 305 | 10,267 | 26,136,888 |
| Share of that pool | — | 3% | 0% |
| Classified as death, per 1,000 reports | 3 | 3 | 9 |
| Classified as injury | 91.1% | 81.6% | 36.2% |
| Classified as malfunction | 8.5% | 15.3% | 62.3% |
| Filed by the manufacturer | 100% | 98.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code HSD
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Dxtend Metaglene | 355 | 14 | 0% |
| Dxtend Glenosphere Std D38mm | 323 | 5 | 0% |
| Dxtend Stand Pe Cup D38 +3mm | 307 | 8 | 0% |
| Dxtend Screw Lock D4 5x36mm | 245 | 11 | 0% |
| Flexible Shaft W/Cir Connector | 152 | 12 | 0% |
| Dxtend Screw No Lock D4 5x18mm | 199 | 21 | 0% |
| Unknown Shoulder Implant | 254 | 8 | 0.8% |
| Dxtend Glenosphere Std D42mm | 227 | 3 | 0% |
| Unknown Shoulder Humeral Stems | 239 | 8 | 1.7% |
| Dxtend Screw Lock D4 5x30mm | 192 | 12 | 0% |
| Dxtend Glenosphere Ecc D42mm | 164 | 0 | 0% |
| Dxtend Stand Pe Cup D38 +6mm | 196 | 2 | 0% |
| Dxtend Stand Pe Cup D38 +9mm | 162 | 5 | 0% |
| Unknown Shoulder Glenosphere | 335 | 24 | 0.3% |
| Delta Xtend | 208 | 205 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Unknown Shoulder Metaglene reports
How many FDA reports name Unknown Shoulder Metaglene?
305 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 16 in the latest 12 months.
What kinds of events are reported?
injury (91.1%), malfunction (8.5%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
osseointegration problem (13.8%), device dislodged or dislocated (12.5%), loss of osseointegration (9.5%), difficult to insert (6.2%) and insufficient device problem information (5.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Unknown Shoulder Metaglene was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.